Navigating the World of Preclinical CROs: Where to Start and How to Focus
You’ve just started a biotech company focused in oncology. You have the IP, an investment, limited infrastructure, and minimal resources. You also have milestones and timelines. What’s your next step? How do you optimize your time and money while making sure you don’t miss a beat to get to your next goal?
Members of our integrated drug discovery team will share their experience and provide considerations for taking the first step that will lead you to a faster outcome.
- Joseph Murphy, PhD, Director, In Vivo, Integrated Drug Discovery, Charles River
- Peter Lockey, PhD, Director, In Vitro, Integrated Drug Discovery, Charles River